Investing Now to Improve the Medicine of Tomorrow
At Finchley Healthcare Ventures, we invest in emerging companies, that develop novel therapies with the potential to address significant unmet medical needs and revolutionize patient care.
We also invest in venture capital funds specializing in life sciences, leveraging their expertise and network to access a diverse range of investment opportunities. Although our offices are located in North America, we have no geographical restriction and will work with scientists, entrepreneurs and investors around the world.
Our Passion
With a passion for advancing healthcare and a keen focus on fostering innovation, we are dedicated to supporting companies developing new and transformative prescription medicines. Our interest is not limited to established modalities such as small molecules and antibodies, we are also seeking breakthrough technologies and transformative ideas, such as nanotechnologies that are pushing the boundaries of medical research and development.
We invest to help companies engaged in the development of innovative drug therapies with the goal of demonstrating proof of concept in humans. We are interested in any disease that is not adequately addressed with current therapies and select companies that have a novel and promising approach aimed at significantly improving the lives of affected patients.
We can invest in companies that are about to start their first clinical trial as well as companies that are further along in their development. We have access to an extensive network of experienced professionals with backgrounds in medicine, pharmaceutical R&D, manufacturing, and commercialization. We can provide valuable insight, advice, strategic direction, and connections to relevant industry partners to help companies optimize their product profile, accelerate their development process, and increase their chances of success.
More Than Capital
